Platelet serotonergic markers in posttraumatic stress disorder

Area of Science:

• Neurobiology
• Psychiatry
• Biochemistry

Background:

• Posttraumatic stress disorder (PTSD) neurobiology involves neurotransmitter system alterations.
• Serotonin (5-hydroxytryptamine, 5-HT) plays a role in PTSD, studied via peripheral platelet models.
• Platelet 5-HT and monoamine oxidase (MAO) activity may indicate mental disturbance markers, but data are controversial.

Purpose of the Study:

• To investigate platelet 5-HT concentration and MAO activity in war veterans with PTSD.
• To compare these markers in veterans with PTSD, veterans without PTSD, and prisoners of war (POWs) with PTSD.
• To assess the association between these markers and PTSD/depression symptom severity.

Main Methods:

• Assessed platelet 5-HT concentration and MAO activity in three drug-free groups: war veterans with PTSD, war veterans without PTSD, and POWs with PTSD.
• Utilized Clinician-Administered PTSD Scale (CAPS) and Montgomery-Asberg Depression Rating Scale (MADRS) for symptom assessment.
• Analyzed correlations between platelet markers and clinical scores.

Main Results:

• No significant differences in platelet 5-HT concentration or MAO activity were found between the groups.
• CAPS scores did not differ between PTSD groups, but MADRS scores were higher in POWs with PTSD.
• No significant correlations were observed between platelet markers and CAPS or MADRS scores.

Conclusions:

• Platelet 5-HT concentration and MAO activity are not significantly altered in drug-free war veterans with or without PTSD, or in POWs with PTSD.
• These peripheral serotonergic markers do not appear to be associated with PTSD symptom severity or comorbid depression in this population.
• Findings suggest these platelet markers may not be reliable biological indicators for PTSD or its associated depressive symptoms in war veterans.